National Cancer Institute; Amended Notice of Meeting
---
identifier: "/us/fr/2011-4775"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2011-4775"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2011-03-03"
last_updated: "2011-03-03"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2011-4775"
document_type: "notice"
publication_date: "2011-03-03"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "76 FR 11800"
fr_volume: 76
---
# National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, March 24, 2011, 12 p.m. to March 24, 2011, 2 p.m., National Institutes of Health, 6116 Executive Boulevard, 706, Rockville, MD 20852 which was published in the *Federal Register* on February 1, 2011, 76 FR 5595.
This notice is amending the name of the committee from “Detection of Cancer Biomarkers on a Universal Nanoplatform” to “Nanotechnology Imaging and Sensing Platforms for Improved Diagnosis of Cancer”. The meeting is closed to the public.
Dated: February 25, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.